These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent. Deeb D; Gao X; Liu YB; Gautam SC J Exp Ther Oncol; 2012; 10(1):51-64. PubMed ID: 22946344 [TBL] [Abstract][Full Text] [Related]
5. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling. Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329 [TBL] [Abstract][Full Text] [Related]
7. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920 [TBL] [Abstract][Full Text] [Related]
8. Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5. Akuetteh PDP; Huang H; Wu S; Zhou H; Jin G; Hong W; Yang H; Lan L; Shangguan F; Zhang Q J Biochem Mol Toxicol; 2022 Nov; 36(11):e23192. PubMed ID: 35929395 [TBL] [Abstract][Full Text] [Related]
9. CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer. Deeb D; Gao X; Arbab AS; Barton K; Dulchavsky SA; Gautam SC Cancers (Basel); 2010 Dec; 2(4):1779-93. PubMed ID: 21799944 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent. Deeb D; Gao X; Liu Y; Varma NR; Arbab AS; Gautam SC Molecules; 2013 Mar; 18(3):3250-65. PubMed ID: 23486104 [TBL] [Abstract][Full Text] [Related]
11. ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells. Gao X; Liu Y; Deeb D; Liu P; Liu A; Arbab AS; Gautam SC Anticancer Res; 2013 Jan; 33(1):215-21. PubMed ID: 23267148 [TBL] [Abstract][Full Text] [Related]
12. Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells. Liu Y; Gao X; Deeb D; Gautam SC Biochem Biophys Res Commun; 2012 Jan; 417(1):570-5. PubMed ID: 22177954 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity. Deeb D; Gao X; Liu Y; Kim SH; Pindolia KR; Arbab AS; Gautam SC Biochem Biophys Res Commun; 2012 Jun; 422(4):561-7. PubMed ID: 22609405 [TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer. Liu Y; Gao X; Deeb D; Arbab AS; Gautam SC Molecules; 2012 Dec; 17(12):14795-809. PubMed ID: 23519253 [TBL] [Abstract][Full Text] [Related]
15. CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells. Deeb D; Gao X; Dulchavsky SA; Gautam SC Anticancer Res; 2007; 27(5A):3035-44. PubMed ID: 17970042 [TBL] [Abstract][Full Text] [Related]
16. c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells. Zou W; Chen S; Liu X; Yue P; Sporn MB; Khuri FR; Sun SY Cancer Biol Ther; 2007 Oct; 6(10):1614-20. PubMed ID: 18253090 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells. Kim KB; Lotan R; Yue P; Sporn MB; Suh N; Gribble GW; Honda T; Wu GS; Hong WK; Sun SY Mol Cancer Ther; 2002 Jan; 1(3):177-84. PubMed ID: 12467212 [TBL] [Abstract][Full Text] [Related]
18. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer. Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762 [TBL] [Abstract][Full Text] [Related]
19. Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer. Gao X; Deeb D; Liu Y; Arbab AS; Divine GW; Dulchavsky SA; Gautam SC Cancers (Basel); 2011; 3(3):3353-69. PubMed ID: 21961053 [TBL] [Abstract][Full Text] [Related]
20. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]